CANCER RESEARCH UK has today (Friday) announced its first cross-company deal as part of its Experimental Cancer Medicine Centre (ECMC) Combinations Alliance.
30 September, 2016
NHS funded Lung Cancer Indicator Detection (LuCID) program to recruit up to 3,000 patients across 21 international sites
27 September, 2016
Leading oncology biopharmaceutical company BerGenBio AS, today released important new preclinical study data on its first-in-class AXL inhibitor, BGB324. The study showed AXL to be a key factor in tumour resistance to the emerging class of new immune checkpoint inhibitors that can be targeted through combination therapy with BGB324. The study data was presented in a poster today at CRI-CIMT-EATI-AACR - The 2nd International Cancer Immunotherapy Conference, in New York.
26 September, 2016
A new biologist-friendly, ‘drag and drop’ computer modelling system for key cancer signalling pathways is expected to speed up drug discovery and reduce the need for ‘wet’ lab experiments. Under a collaboration between AstraZeneca and Microsoft, the tool called BioModel Analyzer (BMA), has already been used to investigate how best to target signalling pathways in different acute myeloid leukaemia (AML) cell lines.
21 September, 2016
Acquisition of West Coast Development & Clinical Manufacturing Specialist Will Add Extensive Formulation Development Capabilities and Expands Bioavailability Enhancement Solutions
19 September, 2016
Researchers at VIB and Ghent University have discovered an important mechanism of sepsis, an overreaction of the body’s immune system to an infection. In this condition, the brain is unable to curb an inflammatory response, causing organ failure or ‘septic shock’. This scenario is the most frequent cause of death in intensive care units. As it turns out, information about infections is passed to our brain via extracellular vesicles, small particles in brain fluid. These insights will be published in the leading scientific journal EMBO Molecular Medicine and might give rise to new strategies to treat sepsis and even other inflammatory conditions.
15 September, 2016
The topic of this month’s newsletter from Drug Discovery Today is “Neurology”.
14 September, 2016
Yeasts were domesticated long before the discovery of microorganisms
08 September, 2016
A ‘super enzyme’ known as PARP3 can help to accelerate the repair of DNA – according to scientists from the University of Sussex.
06 September, 2016
The neuroscience company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG), which develops near patient technologies for the assessment of brain health, has announced results from a new technology feasibility study. The results demonstrate for the first time that consumer grade wearables such as the Apple Watch® and Microsoft Band can be used to measure accurately clinically relevant cognitive performance in everyday life using the Company’s new Cognition Kit software.
02 September, 2016
Collaboration to look into link between epigenetics and respiratory disease.London, UK, 1 September 2016: A charity-industry collaboration has launched an initiative to find new epigenetic drug treatments to improve the lives of millions of people affected by respiratory diseases every year.
02 September, 2016
UC San Diego professor helped develop glowing proteins, illuminating life. Roger Tsien, PhD, co-winner of the 2008 Nobel Prize in chemistry and professor of pharmacology, chemistry and biochemistry at University of California San Diego School of Medicine for 27 years, died August 24 in Eugene, Ore. He was 64.
01 September, 2016